The Europe Remote Patient Monitoring Devices Market was valued at USD 6.4 billion in 2024 and is estimated to grow at a CAGR of 10.9% to reach USD 17.7 billion by 2034.
The expansion of this market is strongly influenced by the growing burden of chronic illnesses, rising personal income levels, higher healthcare investments, rapid improvements in monitoring technologies, and the expanding elderly population across the region. As purchasing power increases and public health systems dedicate more funding to innovation, demand for advanced RPM tools continues to climb. These systems lower hospital-related expenses, enhance long-term disease oversight, and support convenient home-based treatment models. RPM devices, which include a wide range of wearable, implantable, and portable tools, enable continuous health tracking beyond conventional in-clinic evaluations. They measure various physiological parameters such as blood pressure, blood glucose, and heart rate while transmitting information remotely to medical teams. This real-time data flow encourages better patient involvement, quicker clinical evaluations, and stronger adoption of value-driven healthcare frameworks.
The blood glucose monitoring devices segment generated USD 3.5 billion in 2024 and is forecast to grow at a CAGR of 11.1% throughout 2034. Advancements in monitoring technologies have significantly boosted RPM usage for glucose tracking across Europe. Smarter digital systems that provide continuous readings and automated data transmission are transforming diabetes oversight, allowing individuals and clinicians to stay ahead of glucose fluctuations and make more informed treatment choices. Enhanced sensor performance and analytical capabilities are also improving accuracy and overall reliability.
The diabetes segment accounted for a 55.4% share in 2024, reflecting the rising number of individuals requiring frequent glucose assessment and tailored disease management. Continuous monitoring solutions are addressing major limitations of traditional tracking methods by supplying ongoing data that supports improved glycemic stability and personalized care plans.
Germany Remote Patient Monitoring Devices Market reached USD 1.3 billion in 2024. The increasing impact of cardiovascular disorders in the country has intensified the need for continuous oversight of heart-related conditions. RPM tools providing real-time cardiac evaluations and early warning features help reduce emergency interventions, lower hospital readmissions, and promote safer monitoring from home, making them vital to cardiovascular care strategies in the region.
Prominent companies active in the Europe Remote Patient Monitoring Devices Market include Abbott Laboratories, Baxter International, BIOTRONIK, Boston Scientific, Dexcom, F. Hoffmann-La Roche, GE Healthcare, Johnson & Johnson, Koninklijke Philips N.V., Medtronic, OMRON, Sotera Wireless, and Vital Connect. Leading participants in the Europe Remote Patient Monitoring Devices Market are implementing several strategies to strengthen their competitive standing. Many are prioritizing extensive product development to introduce more accurate, user-friendly monitoring technologies tailored for chronic disease management. Companies are also expanding partnerships with healthcare providers to integrate RPM systems into digital care platforms, ensuring smoother adoption within clinical workflows. Strategic acquisitions are being used to broaden product portfolios and accelerate access to specialized monitoring solutions.
This product will be delivered within 2-4 business days.
The expansion of this market is strongly influenced by the growing burden of chronic illnesses, rising personal income levels, higher healthcare investments, rapid improvements in monitoring technologies, and the expanding elderly population across the region. As purchasing power increases and public health systems dedicate more funding to innovation, demand for advanced RPM tools continues to climb. These systems lower hospital-related expenses, enhance long-term disease oversight, and support convenient home-based treatment models. RPM devices, which include a wide range of wearable, implantable, and portable tools, enable continuous health tracking beyond conventional in-clinic evaluations. They measure various physiological parameters such as blood pressure, blood glucose, and heart rate while transmitting information remotely to medical teams. This real-time data flow encourages better patient involvement, quicker clinical evaluations, and stronger adoption of value-driven healthcare frameworks.
The blood glucose monitoring devices segment generated USD 3.5 billion in 2024 and is forecast to grow at a CAGR of 11.1% throughout 2034. Advancements in monitoring technologies have significantly boosted RPM usage for glucose tracking across Europe. Smarter digital systems that provide continuous readings and automated data transmission are transforming diabetes oversight, allowing individuals and clinicians to stay ahead of glucose fluctuations and make more informed treatment choices. Enhanced sensor performance and analytical capabilities are also improving accuracy and overall reliability.
The diabetes segment accounted for a 55.4% share in 2024, reflecting the rising number of individuals requiring frequent glucose assessment and tailored disease management. Continuous monitoring solutions are addressing major limitations of traditional tracking methods by supplying ongoing data that supports improved glycemic stability and personalized care plans.
Germany Remote Patient Monitoring Devices Market reached USD 1.3 billion in 2024. The increasing impact of cardiovascular disorders in the country has intensified the need for continuous oversight of heart-related conditions. RPM tools providing real-time cardiac evaluations and early warning features help reduce emergency interventions, lower hospital readmissions, and promote safer monitoring from home, making them vital to cardiovascular care strategies in the region.
Prominent companies active in the Europe Remote Patient Monitoring Devices Market include Abbott Laboratories, Baxter International, BIOTRONIK, Boston Scientific, Dexcom, F. Hoffmann-La Roche, GE Healthcare, Johnson & Johnson, Koninklijke Philips N.V., Medtronic, OMRON, Sotera Wireless, and Vital Connect. Leading participants in the Europe Remote Patient Monitoring Devices Market are implementing several strategies to strengthen their competitive standing. Many are prioritizing extensive product development to introduce more accurate, user-friendly monitoring technologies tailored for chronic disease management. Companies are also expanding partnerships with healthcare providers to integrate RPM systems into digital care platforms, ensuring smoother adoption within clinical workflows. Strategic acquisitions are being used to broaden product portfolios and accelerate access to specialized monitoring solutions.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, by Product, 2021-2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Application, 2021-2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Country, 2021-2034 ($ Mn)
Chapter 9 Company Profiles
Companies Mentioned
The companies profiled in this Europe Remote Patient Monitoring Devices market report include:- Abbott Laboratories
- Baxter International
- BIOTRONIK
- Boston Scientific
- Dexcom
- F. Hoffmann-La Roche
- GE Healthcare
- Johnson & Johnson
- Koninklijke Philips N.V.
- Medtronic
- OMRON
- Sotera Wireless
- Vital Connect
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 95 |
| Published | December 2025 |
| Forecast Period | 2025 - 2034 |
| Estimated Market Value ( USD | $ 6.4 Billion |
| Forecasted Market Value ( USD | $ 17.7 Billion |
| Compound Annual Growth Rate | 10.9% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 14 |
